Effective as of May 4, 2023, the Board of Directors (the Board) of Talis Biomedical Corporation (the Company) appointed Ms. Kimberly Popovits, who has served as a member of the Board since March 2020, as Lead Independent Director of the Board in accordance with the Company's Amended and Restated Bylaws.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.14 USD | +1.56% | +2.70% | +22.68% |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
Mar. 28 | Talis Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+22.68% | 16.65M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- TLIS Stock
- News Talis Biomedical Corporation
- Talis Biomedical Corporation Appoints Kimberly Popovits as Lead Independent Director